首页|期刊导航|药物分析学报（英文）|Emodin is a novel phosphatidylethanolamine anabolism inhibitor that reprograms lipid metabolism to overcome 5-fluorouracil resistance in colorectal cancer

Emodin is a novel phosphatidylethanolamine anabolism inhibitor that reprograms lipid metabolism to overcome 5-fluorouracil resistance in colorectal cancer

Yanyan Chen Yanchen Liu Zhicheng Gong Zhaohui Huang

药物分析学报（英文）2025，Vol.15Issue(10)：2477-2480,4.

药物分析学报（英文）2025，Vol.15Issue(10)：2477-2480,4.DOI:10.1016/j.jpha.2025.101343

Emodin is a novel phosphatidylethanolamine anabolism inhibitor that reprograms lipid metabolism to overcome 5-fluorouracil resistance in colorectal cancer

Yanyan Chen ¹Yanchen Liu ¹Zhicheng Gong ²Zhaohui Huang²

作者信息

1. Wuxi Cancer Institute,Affiliated Hospital of Jiangnan University,Wuxi,Jiangsu,214062,China
2. Wuxi Cancer Institute,Affiliated Hospital of Jiangnan University,Wuxi,Jiangsu,214062,China||Laboratory of Cancer Epigenetics,Wuxi School of Medicine,Jiangnan University,Wuxi,Jiangsu,214122,China
折叠

摘要

引用本文复制引用

Yanyan Chen,Yanchen Liu,Zhicheng Gong,Zhaohui Huang..Emodin is a novel phosphatidylethanolamine anabolism inhibitor that reprograms lipid metabolism to overcome 5-fluorouracil resistance in colorectal cancer[J].药物分析学报（英文）,2025,15(10):2477-2480,4.

基金项目

This research was financially supported by the National Natural Science Foundation of China(Grant No.:82274115),Top Talent Support Program for Young and Middle-aged People of Wuxi Health Committee,China(Grant Nos.:BJ2023042 and HB2023060),and Wuxi Medical Key Discipline,China(Grant No.:ZDXK2021002).We thank Associate Professor Kaisa Cui(Affiliated Hospital of Jiangnan University,China)for his kind assistance in data processing. （Grant No.:82274115）

药物分析学报（英文）

ISSN：2095-1779

访问量0

下载量0

段落导航